Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Danazol for heavy menstrual bleeding.

H Beaumont, C Augood, K Duckitt

    The Cochrane Database of Systematic Reviews
    |July 20, 2007
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tau positron emission tomography imaging in C9orf72 repeat expansion carriers.

    European journal of neurology·2019
    Same author

    Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis.

    Acta psychiatrica Scandinavica·2014
    Same author

    Localization of mGluR5, GABAB, GABAA, and cannabinoid receptors on the vago-vagal reflex pathway responsible for transient lower esophageal sphincter relaxation in humans: an immunohistochemical study.

    Neurogastroenterology and motility·2012
    Same author

    Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations.

    Allergy·2011
    Same author

    Summary of guidance for the use of fluorides.

    The New Zealand dental journal·2009
    Same author

    The GABA(B) receptor agonist AZD9343 inhibits transient lower oesophageal sphincter relaxations and acid reflux in healthy volunteers: a phase I study.

    Alimentary pharmacology & therapeutics·2009
    Same journal

    Interventions to prevent or cease electronic cigarette use in children and adolescents.

    The Cochrane database of systematic reviews·2026
    Same journal

    Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

    The Cochrane database of systematic reviews·2026
    Same journal

    Interventions for smoking cessation in inpatient psychiatry settings.

    The Cochrane database of systematic reviews·2026
    Same journal

    Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

    The Cochrane database of systematic reviews·2026
    Same journal

    Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

    The Cochrane database of systematic reviews·2026
    Same journal

    Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

    The Cochrane database of systematic reviews·2026
    See all related articles

    Danazol effectively reduces heavy menstrual bleeding (HMB) compared to other medical treatments. However, its use may be limited by side effects and the need for ongoing treatment, with small trial sizes impacting recommendations.

    Area of Science:

    • Gynecology
    • Pharmacology

    Background:

    • Heavy menstrual bleeding (HMB) significantly impacts premenopausal women's health.
    • Medical therapies are preferred over surgery for HMB, but treatment effectiveness varies.
    • Danazol, a synthetic steroid, induces endometrial atrophy, reducing menstrual loss.

    Purpose of the Study:

    • To evaluate the effectiveness and tolerability of Danazol for treating heavy menstrual bleeding in women of reproductive age.

    Main Methods:

    • Systematic review of randomized controlled trials (RCTs) comparing Danazol to placebo or other medical treatments for HMB.
    • Searched multiple databases including Cochrane, MEDLINE, EMBASE, and CINAHL up to April 2007.
    • Nine RCTs involving 353 women were included, with data extraction and quality assessment by two independent reviewers.

    Related Experiment Videos

    Main Results:

    • Danazol demonstrated greater efficacy than placebo, progestogens, NSAIDs, and OCPs in reducing menstrual blood loss (MBL), though confidence intervals were wide.
    • Danazol treatment resulted in more adverse events compared to NSAIDs and progestogens.
    • Danazol significantly reduced the duration of menses compared to NSAIDs and progesterone-releasing IUDs.

    Conclusions:

    • Danazol appears effective for HMB but may be limited by side effects and the need for continuous treatment.
    • Small trial sizes and limited data restrict definitive clinical recommendations.
    • Further research on Danazol for HMB is unlikely, and this review is unlikely to be updated.